Patent-family-84369540
Applicants:
- Novo Nordisk (Denmark) [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
A capsule device (200) suitable for ingestion into a lumen of the gastrointestinal tract of a patient, the capsule device (200) configured as a self-righting capsule comprising: a) a capsule housing (210, 220) comprising a compartment and an exit opening (224), b) a tissue penetrating member (230, 260, 270), and c) an actuator arrangement (240, 250) configured to move the tissue penetrating member (230, 260, 270) into the lumen wall at a target location. The actuator arrangement (240, 250) comprises a drive spring (240) with a first (240a) and a second helical portion (240b) being wound about at least a portion of the first helical portion (240a), wherein a transitional portion of the second helical portion (240b) connects to a transitional portion of the first helical portion (240a). One of the helical portions (240a, b) acts as a tension spring and the other as a compression spring.
Patent Family Records (1)
CAPSULE DEVICE WITH IMPROVED ACTUATOR ARRANGEMENT
NOVO NORDISK AS, Novo Nordisk (Denmark) PEDERSEN SIMON, MARSTRAND ANDERS, SIGURDARSON NÖKKVI, (...more)
2024, WO-2024115734-A1